The current valuation score of BridgeBio Pharma Inc is 9.41, ranking 27 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -22.13, which is -90.07% below the recent high of -2.20 and -8.73% above the recent low of -24.07.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.